drugset / Trial / NCT03265808
Allogeneic Human Mesenchymal Stem Cell Infusion vs Placebo in Alcohol Use Disorder and Major Depression.
Phase 1/2
Completed
31 enrolled
Ihsan M Salloum, MD, MPH
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to look at the safety of a study treatment with stem cells in Alcohol Use Disorder And Major Depression (AUD-MD) subjects.
Timeline
- Start
- 2018-03-18
- Primary completion
- 2025-07-30
- Completion
- 2025-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allogeneic Human Mesenchymal Stem Cells | Cell therapy | 1e+08 cells | Intravenous |